Skip to content

Frontiers in Immunology

ISSN 1664-3224

6 papers in the library · 503 citations · publishing 2015-2026

Papers

Sort Most recent Most cited

Serum inflammatory cytokines in the progression of depression.

Frontiers in Immunology 2026 Qing Feng, Zhen Yuan, Qi An et al. 1 citation

Depression is increasingly recognized as a multifactorial disorder in which immune dysregulation contributes substantially to disease initiation, progression, and treatment response. Among the immune mediators implicated, serum inflammatory cytokines-including IL-1β, IL-6, TNF-α, IFN-γ, and C-reactive protein-have emerged as key links between peripheral inflammation and central nervous system...

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.

Frontiers in Immunology 2025 David Qixiang Chen, José Adalberto Inzunza Domínguez, Juan Manuel Valle Uzeta et al. 3 citations

Multiple sclerosis (MS) is a debilitating neurodegenerative disease characterized by demyelination and neuronal loss. Traditional therapies often fail to halt disease progression or reverse neurological deficits. Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients...

In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor

Frontiers in Immunology January 14, 2022 Faez Iqbal Khan, Fakhrul Hassan, Dakun Lai 34 citations

Various metabolites identified with therapeutic mushrooms have been found from different sources and are known to have antibacterial, antiviral, and anticancer properties. Over thousands soil growth-based mushroom metabolites have been discovered, and utilized worldwide to combat malignancy. In this study, psilocybin-mushroom that contains the psychedelic compounds such as psilacetin, psilocin,...

DOI: 10.3389/fimmu.2021.794780 (opens in new tab) Psilocybin Cytokine storm Pharmacology Psychotomimetic +4

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

Frontiers in Immunology September 21, 2018 José A. Crippa, Francisco Silveira Guimarães, Alline Cristina Campos et al. 312 citations

Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subjective effects of marijuana. Objectives: The aim of the present review is to describe the main advances in the development of the experimental and clinical use of cannabidiol CBD in neuropsychiatry. Methods: A non-systematic search was performed for studies...

What Is the Molecular Signature of Mind-Body Interventions? A Systematic Review of Gene Expression Changes Induced by Meditation and Related Practices.

Frontiers in Immunology June 16, 2017 Ivana Buric, Miguel Farias, Jonathan Jong et al.

There is considerable evidence for the effectiveness of mind-body interventions (MBIs) in improving mental and physical health, but the molecular mechanisms of these benefits remain poorly understood. One hypothesis is that MBIs reverse expression of genes involved in inflammatory reactions that are induced by stress. This systematic review was conducted to examine changes in gene expression...

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities

Frontiers in Immunology July 14, 2015 Attila Szabo 153 citations

Classical psychedelics are psychoactive substances, which, besides their psychopharmacological activity, have also been shown to exert significant modulatory effects on immune responses by altering signaling pathways involved in inflammation, cellular proliferation, and cell survival via activating NF-κB and mitogen-activated protein kinases. Recently, several neurotransmitter receptors...

DOI: 10.3389/fimmu.2015.00358 (opens in new tab) Cognitive science Data science